Respiratory

A new study identifies airway eosinophilia as a distinct, corticosteroid-responsive subtype of COPD, marked by heightened type 2 inflammation and gene expression changes.

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Rare genetic variants and common polygenic risk scores independently influence survival in idiopathic pulmonary fibrosis.

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups – read more about the latest trial results.

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.

Smoking may reduce the risk of developing ulcerative colitis and alleviate disease severity in existing cases.

Statistical analysis shows combined breathing and stretching exercises significantly improve respiratory function and exercise capacity in COPD patients.

Youth using varenicline with brief behavioral support were far more likely to quit vaping than those given placebo or usual care, a new randomized trial finds.